Clinical Physiology of Circulation

ISSN 1814-6910 (Print)
ISSN 2410-9134 (Online)

 

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Issue's catalogue ➤ КФК. 2021; 18 (1): 1-92 ➤ Гематологические особенности острого коронарного синдрома и других кардиальных событий

Hematological features of acute coronary syndrome and other cardiac events

Authors: Gitelson D.G.1,2, 2, Faybushevich A.G.1, Maksimkin D.A.1, Veretnik G.I.1, Baranovich V.Yu.1, Gitelzon E.A.1, Vasilyev A.E.2, Danishyan K.I. 2

Company:
1 Peoples’ Friendship University of Russia, Moscow, 117198, Russian Federation
2 National Research Center for Hematology, Moscow, 125167, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814-6910-2021-18-1-24-29

UDC: 616.132.2-15

Link: Clinical Physiology of Blood Circulaiton. 2021; 1 (18): 24-29

Quote as: Gitelson D.G., Faybushevich A.G., Maksimkin D.A., Veretnik G.I., Baranovich V.Yu., Gitelzon E.A., Vasilyev A.E., Danishyan K.I. Hematological features of acute coronary syndrome and other cardiac events. Clinical Physiology of Circulation. 2021; 18 (1): 24–9 (in Russ.). DOI: 10.24022/1814-6910-2021-18-1-24-29

Keywords:  hematological features acute coronary syndrome ardiovascular complications

Received / Accepted:  28.08.2020 / 27.10.2020

Download
Full text:  

Abstract

The review of hematological features of acute coronary syndrome and other cardiac events is presented, which is based on a search for scientific medical articles in the Pubmed electronic database. Hematological parameters and features of acute coronary syndrome and other cardiac events provide accessible, safe and reliable prognostic data for identifying patients at high risk of cardiovascular complications. And also in this way, it is possible to detect acute coronary syndrome at an early stage of development. It should be emphasized that in clinical practice, if acute cardiac pathology is suspected, attention should be paid not only to cardiomarkers. However, it is worth remembering that the hematological parameters are affected by comorbid conditions: anemia, thrombocytopenia, renal failure, diabetes mellitus and arterial hypertension

References

  1. Falk E., Nakano M., Bentzon J.F., Finn A.V., Virmani R. Update on acute coronary syndromes: the pathologists’ view. Eur. Heart J. 2013; 34 (10): 719–28. DOI: 10.1093/eurheartj/ehs411
  2. Dutta P., Courties G., Wei Y., Leuschner F., Gorbatov R., Robbinset C.S. et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012; 487 (7407): 325–9. DOI: 10.1038/nature11260
  3. Balta S., Kurtoglu E., Kucuk U., Demirkol S., Ozturk C. Neutrophil–lymphocyte ratio as an important assessment tool. Exp. Rev. Cardiovasc. Ther. 2014; 12 (5): 537–8. DOI: 10.1586/14779072.2014.902309
  4. Madjid M., Awan I., Willerson J.T., Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J. Am. Coll. Cardiol. 2004; 44 (10): 1945–56. DOI: 10.1016/j.jacc.2004.07.056
  5. Ensrud K., Grimm R.H. The white blood cell count and risk for coronary heart disease. Am. Heart J. 1992; 124 (1): 207–13. DOI: 10.1016/0002-8703(92)90942-o
  6. Yarnell J.W., Baker I.A., Sweetnam P.M., Bainton D., O’Brien J.R., Whitehead P.J. et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991; 83 (3): 836–44. DOI: 10.1161/01.cir.83.3.836
  7. Grau A.J., Boddy A.W., Dukovic D.A., Buggle F., Lichy C., Brandt T. et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004; 35 (5): 1147–52. DOI: 10.1161/01.str. 0000124122.71702.64
  8. Sabatine M.S., Morrow D.A., Cannon C.P., Murphy S., Demopoulos L.A., DiBattiste P.M. et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 2002; 40 (10): 1761–8. DOI: 10.1016/s0735-1097(02)02484-1
  9. Cannon C.P., McCabe C.H., Wilcox R.G., Bentley J.H., Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am. J. Cardiol. 2001; 87 (5): 636–9. DOI: 10.1016/s0002-9149(00)014442
  10. Barron H.V., Cannon C.P., Murphy S.A., Braunwald E., Gibson C.M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation. 2000; 102 (19): 2329–34. DOI: 10.1161/01.cir.102.19.2329
  11. Gurm H.S., Bhatt D.L., Gupta R., Ellis S.G., Topol E.J., Lauer M.S. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am. Heart J. 2003; 146 (4): 692–8. DOI: 10.1016/s0002-8703(03)00230-8
  12. Chia S., Nagurney J.T., Brown D.F., Raffel O.C., Bamberg F., Senatore F. et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am. J. Cardiol. 2009; 103 (3): 333–7. DOI: 10.1016/j.amjcard.2008.09.085
  13. Sezer M., Okcular I., Goren T., Oflaz H., Nisanci Y., Umman B. et al. Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2007; 93 (3): 313–8. DOI: 10.1136/hrt.2006.094763
  14. Mangold A., Alias S., Scherz T., Hofbauer T., Jakowitsch J., Panzenbock A. et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ. Res. 2015; 116 (7): 1182–92. DOI: 10.1161/circresaha.116.304944
  15. Major A.S., Fazio S., Linton M.F. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arteriosc. Thromb. Vasc. Biol. 2002; 22 (11): 1892–8. DOI: 10.1161/01.atv.0000039169.47943.ee
  16. Vaduganathan M., Ambrosy A.P., Greene S.J., Mentz R.J., Subacius H.P., Maggioni A.P. et al. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circul. Heart Fail. 2012; 5 (6): 750–8. DOI: 10.1161/circheartfailure.112.970525
  17. Zouridakis E.G., Garcia-Moll X., Kaski J.C. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am. J. Cardiol. 2000; 86 (4): 449–51. DOI: 10.1016/s0002-9149(00)00963-2
  18. Duffy B.K., Gurm H.S., Rajagopal V., Gupta R., Ellis S.G., Bhatt D.L. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am. J. Cardiol. 2006; 97 (7): 993–6. DOI: 10.1016/j.amjcard.2005.10.034
  19. Kalay N., Dogdu O., Koc F., Yarlioglues M., Ardic I., Akpek M. et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology. 2012; 63 (3): 213–7. DOI: 10.1177/0003319711412763
  20. Wang X., Zhang G., Jiang X., Zhu H., Lu Z., Xu L. Neutrophil to lymphocyte ratio in relation to risk of allcause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014; 234 (1): 206–13. DOI: 10.1016/j.atherosclerosis.2014.03.003
  21. Tamhane U.U., Aneja S., Montgomery D., Rogers E.K., Eagle K.A., Gurm H.S. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am. J. Cardiol. 2008; 102 (6): 653–7. DOI: 10.1016/j.amjcard.2008.05.006
  22. Nunez J., Nunez E., Bodi V., Sanchis J., Minana G., Mainar L. et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am. J. Cardiol. 2008; 101 (6): 747–52. DOI: 10.1016/j.amjcard. 2007.11.004
  23. Akpek M., Kaya M.G., Lam Y.Y., Sahin O., Elcik D., Celik T. et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am. J. Cardiol. 2012; 110 (5): 621–7. DOI: 10.1016/j.amjcard.2012.04.041
  24. Sahin D.Y., Elbasan Z., Gür M., Yildiz A., Akpinar O., Icen Y.K. et al. Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction. Angiology. 2013; 64 (6): 423–9. DOI: 10.1177/0003319712453305
  25. Yaylak B., Ede H., Baysal E., Altintas B., Akyuz S., Sevuk U. et al. Neutrophil/lymphocyte ratio is associated with right ventricular dysfunction in patients with acute inferior ST-segment elevation myocardial infarction. Cardiol. J. 2016; 23 (1): 100–6. DOI: 10.5603/cj.a2015.0061
  26. Azab B., Zaher M., Weiserbs K.F., Torbey E., Lacossiere K., Gaddam S. et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am. J. Cardiol. 2010; 106 (4): 470–6. DOI: 10.1016/j.amjcard.2010.03.062
  27. Chatterjee S., Chandra P., Guha G., Kalra V., Chakraborty A., Frankel R. et al. Pre-procedural elevated white blood cell count and neutrophil-lymphocyte (N/L) ratio are predictors of ventricular arrhythmias during percutaneous coronary intervention. Cardiovasc. Hematol. Dis. Drug Targ. 2011; 11 (2): 58–60. DOI: 10.2174/187152911798346981
  28. Ayca B., Akin F., Celik O., Sahin I., Yildiz S.S., Avci I.I. et al. Neutrophil to lymphocyte ratio is related to stent thrombosis and high mortality in patients with acute myocardial infarction. Angiology. 2015; 66 (6): 545–52. DOI: 10.1177/0003319714542997
  29. ltun B., Turkon H., Tasolar H., Beggi H., Altun M., Temiz A. et al. The relationship between high-sensitive troponin T, neutrophil lymphocyte ratio and SYNTAX score. Scand. J. Clin. Lab. Invest. 2014; 74 (2): 108–15. DOI: 10.3109/00365513.2013.860619
  30. Ergelen M., Uyarel H., Altay S., Kul S., Ayhan E., Isik T. et al. Predictive value of elevated neutrophil to lymphocyte ratio in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Clin. Appl. Thromb. Hemost. 2014; 20 (4): 427–32. DOI: 10.1177/1076029612473516
  31. Sawant A.C., Adhikari P., Narra S.R., Srivatsa S.V., Mills P.K., Srivatsa S.S. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol. J. 2014; 21 (5): 500–8. DOI: 10.5603/cj.a2013.0148
  32. Sertoglu E., Tapan S., Uyanik M. Important details about the red cell distribution width. J. Ather. Thromb. 2015; 22 (2): 219–20. DOI: 10.5551/jat.27573 28 Reviews Clinical Physiology of Circulation. 2021; 18 (1). DOI: 10.24022/1814-6910-2021-18-1-24-29
  33. Patel K.V., Mohanty J.G., Kanapuru B., Hesdorffer C., Ershler W.B., Rifkind J.M. Association of the red cell distribution width with red blood cell deformability. Adv. Exp. Med. Biol. 2013; 765: 211–6. DOI: 10.1007/978-1-4614-4989-8_29
  34. Felker G.M., Allen L.A., Pocock S.J., Shaw L.K., McMurray J.V., Pfeffer M.A. et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J. Am. Coll. Cardiol. 2007; 50 (1): 40–7. DOI: 10.1016/j.jacc.2007.02.067
  35. Arbel Y., Raz R., Weitzman D., Steinvil A., Zeltser D., Berliner S. et al. Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality: a population-based study. Thromb. Haemost. 2014; 111 (2): 300–7. DOI: 10.1160/TH13-07-0567
  36. Ye Z., Smith C., Kullo I.J. Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. Am. J. Cardiol. 2011; 107 (8): 1241–5. DOI: 10.1016/j.amjcard.2010.12.023
  37. Seyhan E.C., Ozgul M.A., Tutar N., Omur I.M., Uysal A., Altin S. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD J. Chron. Obstr. Pulm. Dis. 2013; 10 (4): 416–24. DOI: 10.3109/15412555.2012.758697
  38. Lippi G., Targher G., Montagnana M., Salvagno G.L., Zoppini G., Guidi G.C. Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scand. J. Clin. Lab. Invest. 2008; 68 (8): 745–8. DOI: 10.1080/00365510802213550
  39. Jo Y.H., Kim K., Lee J.H., Kang C., Kim T., Park H.M. et al. Red cell distribution width is a prognostic factor in severe sepsis and septic shock. Am. J. Emerg. Med. 2013; 31 (3): 545–8. DOI: 10.1016/j.ajem.2012.10.017
  40. Soderholm M., Borne Y., Hedblad B., Persson M., Engstrom G. Red cell distribution width in relation to incidence of stroke and carotid atherosclerosis: a population-based cohort study. PLoS One. 2015; 10 (5): e0124957. DOI: 10.1371/journal.pone.0124957
  41. Ani C., Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J. Neurol. Sci. 2009; 277 (1–2): 103–8. DOI: 10.1016/j.jns.2008.10.024
  42. Hampole C.V., Mehrotra A.K., Thenappan T., Gomberg-Maitland M., Shah S.J. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am. J. Cardiol. 2009; 104 (6): 868–72. DOI: 10.1016/j.amjcard.2009.05.016
  43. Tonelli M., Sacks F., Arnold M., Moye L., Davis B., Pfeffer M. et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008; 117 (2): 163–8. DOI: 10.1161/circulationaha.107.727545
  44. Dabbah S., Hammerman H., Markiewicz W., Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am. J. Cardiol. 2010; 105 (3): 312–7. DOI: 10.1016/j.amjcard.2009.09.027
  45. Uyarel H., Ergelen M., Cicek G., Kaya M.G., Ayhan E., Turkkan C. et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron. Art. Dis. 2011; 22 (3): 138–44. DOI: 10.1097/mca.0b013e328342c77b
  46. Isik T., Kurt M., Ayhan E., Tanboga I.H., Ergelen M., Uyarel H. The impact of admission red cell distribution width on the development of poor myocardial perfusion after primary percutaneous intervention. Atherosclerosis. 2012; 224 (1): 143–9. DOI: 10.1016/j.atherosclerosis.2012.06.017
  47. Lippi G., Filippozzi L., Montagnana M., Salvagno G.L., Franchini M., Guidi G.C. et al. Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin. Chem. Lab. Med. 2009; 47 (3): 353–7. DOI: 10.1515/cclm.2009.066
  48. Akin F., Kose N., Ayc,a B., Katkat F., Duran M., Uysal O.K. et al. Relation between red cell distribution width and severity of coronary artery disease in patients with acute myocardial infarction. Angiology. 2013; 64 (8): 592–6. DOI: 10.1177/0003319712461931
  49. Nikolsky E., Grines C.L., Cox D.A., Garcia E., Tcheng J.E., Sadeghi M. et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am. J. Cardiol. 2007; 99 (8): 1055–61. DOI: 10.1016/j.amjcard.2006.11.066
  50. Lordkipanidze M., Diodati J.G., Turgeon J., Schampaert E., Palisaitis D.A., Pharand C. Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin. Int. J. Cardiol. 2010; 143 (1): 43–50. DOI: 10.1016/j.ijcard.2009.01.037
  51. Croce K., Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr. Opin. Hematol. 2007; 14: 55–61. DOI: 10.1097/00062752-200701000- 00011
  52. Vagdatli E., Gounari E., Lazaridou E., Katsibourlia E., Tsikopoulou F., Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010; 14 (1): 28–32.
  53. Asher V., Lee J., Innamaa A., Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin. Transl. Oncol. 2011; 13 (7): 499–503. DOI: 10.1007/s12094-011-0687-9
  54. Azab B., Shah N., Akerman M., McGinn J.T. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J. Thromb. Thrombol. 2012; 34 (3): 326–34. DOI: 10.1007/s11239-012-0718-6
  55. Sun X.P., Li J., Zhu W.W., Li D.B., Chen H., Li H.W. et al. Impact of platelet-to-lymphocyte ratio on clinical outcomes in patients with ST-segment elevation myocardial infarction. Angiology. 2017; 68 (4): 346–53. DOI: 10.1177/0003319716657258
  56. Yildiz A., Yuksel M., Oylumlu M., Polat N., Akyuz A., Acet H. et al. The utility of the platelet–lymphocyte ratio for predicting no reflow in patients with ST-segment elevation myocardial infarction. Clin. Appl. Thromb. Hemost. 2015; 21 (3): 223–8. DOI: 10.1177/1076029613519851
  57. Kowara M., Grodecki K., Huczek Z., Puchta D., Paczwa K., Rymuza B. et al. Platelet distribution width predicts left ventricular dysfunction in patients with acute coronary syndromes treated with percutaneous coronary intervention. Kardiol. Pol. 2017; 75 (1): 42–7. DOI: 10.5603/KP.a2016.0137
  58. Bekler A., Ozkan M.T., Tenekecioglu E., Gazi E., Yener A.U., Temiz A. et al. Increased platelet distribution width is associated with severity of coronary artery disease in patients with acute coronary syndrome. Angiology. 2015; 66 (7): 638–43. DOI: 10.1177/0003319714545779
  59. Cetin M., Bakirci E.M., Baysal E., Tasolar H., Balli M., Cakici M. et al. Increased platelet distribution width is associated with ST-segment elevation myo-cardial infarction and thrombolysis failure. Angiology. 2014; 65 (8): 737–43. DOI: 10.1177/0003319713520068
  60. Celik T., Kaya M.G., Akpek M., Gunebakmaz O., Balta S., Sarli B. et al. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction. Angiology. 2015; 66 (2): 155–62. DOI: 10.1177/000331971351349

About Authors

  • Daniel G. Gitelson, Postgraduate; ORCID
  • Aleksandr G. Faybushevich, Cand. Med. Sc., Chief of Chair;; ORCID
  • Daniil A. Maksimkin, Cand. Med. Sc., Associate Professor; ORCID
  • Galina I. Veretnik, Cand. Med. Sc., Head of Academic Department; ORCID
  • Vladislav Yu. Baranovich, Cand. Med. Sc., Associate Professor; ORCID
  • Ekaterina A. Gitelzon, Assistant, Postgraduate; ORCID
  • Aleksandr E. Vasilyev, Cand. Med. Sc.; ORCID
  • Karen I. Danishyan, Dr. Med. Sc., Head of Department; ORCID

 If you found mistakes, select text and press Alt+A